A. Recruitment Developmental funds to support the recruitment of new investigators to the IUSCC will be critical in the next funding cycle to accomplish our strategic plan of the Center. During the current funding cycle, developmental funds were used to support the growth of research programs through targeted faculty recruitments. Investigators were recruited to all four IUSCC programs (Cancer Control, Hematopoiesis, Microenvironment and Immunology, Breast Cancer, and Experimental and Developmental Therapeutics) to accomplish the strategic objectives of the Center which had been identified as needing to increase our Gl, breast, epidemiology, lung cancer, and hematopoiesis faculty as well as cancer control members. Eighteen faculty members were successfully recruited with primary appointments in eight departments. Of these, ten now hold peer reviewed federal cancer research grants. All recruitment objectives discussed in the previous CCSG application were addressed (behavioral science and basic science focused on Gl and ovarian cancers). Future recruiting efforts in the upcoming grant cycle will be targeted toward expanding our Breast Cancer, Cancer Control and EOT Programs as well as the developing programs Molecular and Environmental Carcinogenesis and Tumor Microenvironment, outlined in the IUSCC Strategic Plan. CCSG funds are often a critical component of the packages that we use to recruit top candidates and provide the Cancer Center Director with real input into the recruitment of top cancer investigators into the institution. B. Pilot Projects: Developmental funds are also pivotally important for support of pilot research projects. Until September 2006, the IUSCC allocated pilot project funds by internal review of applications responding to specific RFA's. These RFA's could target a specific cancer type or research program. Some required collaboration with members of the Purdue Cancer Center and were jointly funded by both Centers. Review criteria included scientific relevance, collaboration and potential for future peer-reviewed funding. The IUSCC supported nineteen such projects, which are shown in Table 1 later in this section. Traditional use of funds for pilot funding of IUSCC projects changed dramatically when in September 2006, IUSCC Senior Leaders began a new and innovative approach for the allocation of pilot research funds.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Center Core Grants (P30)
Project #
Application #
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Indiana University-Purdue University at Indianapolis
United States
Zip Code
Kedage, Vivekananda; Selvaraj, Nagarathinam; Nicholas, Taylor R et al. (2016) An Interaction with Ewing's Sarcoma Breakpoint Protein EWS Defines a Specific Oncogenic Mechanism of ETS Factors Rearranged in Prostate Cancer. Cell Rep 17:1289-1301
Nudelman, Kelly N H; McDonald, Brenna C; Wang, Yang et al. (2016) Cerebral Perfusion and Gray Matter Changes Associated With Chemotherapy-Induced Peripheral Neuropathy. J Clin Oncol 34:677-83
Hoggatt, Jonathan; Hoggatt, Amber F; Tate, Tiffany A et al. (2016) Bleeding the laboratory mouse: Not all methods are equal. Exp Hematol 44:132-137.e1
Haley, James; Tomar, Sunil; Pulliam, Nicholas et al. (2016) Functional characterization of a panel of high-grade serous ovarian cancer cell lines as representative experimental models of the disease. Oncotarget 7:32810-20
Radovich, Milan; Solzak, Jeffrey P; Hancock, Bradley A et al. (2016) A large microRNA cluster on chromosome 19 is a transcriptional hallmark of WHO type A and AB thymomas. Br J Cancer 114:477-84
Li, Wei; Liu, Liangyi; Gomez, Aurelie et al. (2016) Proteomics analysis reveals a Th17-prone cell population in presymptomatic graft-versus-host disease. JCI Insight 1:
Champion, Victoria L; Rawl, Susan M; Bourff, Sara A et al. (2016) Randomized trial of DVD, telephone, and usual care for increasing mammography adherence. J Health Psychol 21:916-26
Meijome, Tomas E; Baughman, Jenna T; Hooker, R Adam et al. (2016) C-Mpl Is Expressed on Osteoblasts and Osteoclasts and Is Important in Regulating Skeletal Homeostasis. J Cell Biochem 117:959-69
Richine, B M; Virts, E L; Bowling, J D et al. (2016) Syk kinase and Shp2 phosphatase inhibition cooperate to reduce FLT3-ITD-induced STAT5 activation and proliferation of acute myeloid leukemia. Leukemia 30:2094-2097
Masters, Andrea R; Gufford, Brandon T; Lu, Jessica Bo Li et al. (2016) Chiral Plasma Pharmacokinetics and Urinary Excretion of Bupropion and Metabolites in Healthy Volunteers. J Pharmacol Exp Ther 358:230-8

Showing the most recent 10 out of 220 publications